VASTox: Fishing for business

While VASTox plc is not the first company formed around zebrafish biology, it thinks its medicinal chemistry capabilities and focused ambitions differentiate it from its pre-bubble predecessors. The company says its integrated screening technology and medicinal chemistry allow it to accurately identify drug toxicities at an earlier stage in development, thereby reducing the cost of failure in late preclinical testing.

VASTox (LSE:VOX, Oxford, U.K.) is using its service contracts to both fund and inform discovery and development for its own account...